The peptide problem: Hype is outrunning the evidence FDA to Convene Expert Panel on Expanding Access to Peptides Amid Safety, Regulatory Debate AJMC FDA's Overreach on Compounded Peptides The US FDA has established a green list of imported GLP 1 drug ingredients deemed safe and allowed into the country, while keeping out those from unverified foreign sources. The agency had identified BPC 157 and TB 500: Injury Healing Peptides Jonathan L. Glashow posted on the topic LinkedIn Integrating Quality into Clinical Trials